Coherus Oncology Inc
CHRS
NASDAQ
Biotechnology
$1.20
USD
+0.06 (+5.26%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $176.13M
Volume 635.9K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
CRBP | Corbus Pharmaceuticals Holdings Inc | $196.89M | - | - | - | |
KRRO | Korro Bio Inc | $195.70M | - | -62.1% | - | |
VYGR | Voyager Therapeutics Inc | $193.35M | - | -19.1% | - | |
PYXS | Pyxis Oncology Inc | $190.70M | - | -14.2% | - | |
ABOS | Acumen Pharmaceuticals Inc | $184.18M | - | - | - | |
CHRS | Coherus Oncology Inc | $176.13M | - | -64.3% | - | |
NKTX | Nkarta Inc | $164.38M | - | - | - | |
TNYA | Tenaya Therapeutics Inc | $164.36M | - | - | - | |
HUMA | Humacyte Inc | $148.30M | - | +231.7% | - |
Top Peer by Growth
Humacyte Inc
+231.7% YoY Revenue
Best 1-Year Return
Pyxis Oncology Inc
+205.8% Return